Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07 sept. 2023 08h00 HE
|
Enlivex Therapeutics Ltd
Nes-Ziona, Israel, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage macrophage reprogramming immunotherapy company, today announced that company...